
Gabniv-P Tablet
Marketer
Vinson Pharma Pvt Ltd
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Gabniv-P Tablet
Neuropathic pain is effectively managed by Gabniv-P, a combination medication. Its mechanism involves interrupting pain signal transmission to the brain, thus reducing pain perception. Gabniv-P tablets are administered orally, with or without food, ideally before sleep. Maintaining consistent daily timing ensures stable blood levels. Adhere strictly to your physician's prescribed dosage and duration, as this medication can be habit-forming. Missed doses should be taken immediately upon recall. Complete the entire course of treatment, regardless of symptom improvement. Discontinuation requires prior consultation with your doctor to avoid potential complications. Common side effects include constipation, urinary difficulty, weight gain, fatigue, and dry mouth. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the effects are known. Weight gain may be experienced; mitigate this with regular exercise and a balanced diet. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your physician immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and provide a complete list of current medications, as interactions may impact efficacy or alter its function. Furthermore, inform your doctor if you are pregnant, considering pregnancy, or breastfeeding.
Primary Ingredients of Gabniv-P Tablet
There is no text provided to rephrase.
Uses of Gabniv-P Tablet
Managing neuropathic pain
Major Benefits of Gabniv-P Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The tablet should be swallowed whole; do not crush, chew, or break it. Gabniv-P Tablets can be taken with or without food, although consistent timing is recommended.
Common Side effects of Gabniv-P Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Gabniv-P Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gabniv-P Tablets can be consumed with or without food, however, consistent timing is recommended.
How Gabniv-P Tablet works:
Gabniv-P tablets contain pregabalin and nortriptyline, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain transmission by modulating nerve cell calcium channels. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline, neurotransmitters that inhibit pain signal propagation within the brain. This combined action provides effective relief from nerve-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gabniv-P tablets and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Gabniv-P Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Gabniv-P Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Gabniv-P Tablet side effects, due to potential drowsiness induced by the medication.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Gabniv-P tablets, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Gabniv-P Tablet in individuals with liver impairment is likely safe. Existing evidence indicates dose modification may not be necessary, however, medical advice is recommended.
What if you forget to take Gabniv-P Tablet :
Should you forget a Gabniv-P Tablet dose, take it promptly. If, however, your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Gabniv-P Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurobiology |
